The NF-κB Pathway and Cancer Stem Cells

Amanda L. Rinkenbaugh, Albert S. Baldwin

Research output: Contribution to journalReview articlepeer-review

204 Scopus citations

Abstract

The NF-κB transcription factor pathway is a crucial regulator of inflammation and immune responses. Additionally, aberrant NF-κB signaling has been identified in many types of cancer. Downstream of key oncogenic pathways, such as RAS, BCR-ABL, and Her2, NF-κB regulates transcription of target genes that promote cell survival and proliferation, inhibit apoptosis, and mediate invasion and metastasis. The cancer stem cell model posits that a subset of tumor cells (cancer stem cells) drive tumor initiation, exhibit resistance to treatment, and promote recurrence and metastasis. This review examines the evidence for a role for NF-κB signaling in cancer stem cell biology.

Original languageEnglish (US)
JournalCells
Volume5
Issue number2
DOIs
StatePublished - Apr 6 2016
Externally publishedYes

Keywords

  • Cancer
  • Cancer stem cells
  • NF-κB
  • Self-renewal
  • Tumor-initiating cells

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'The NF-κB Pathway and Cancer Stem Cells'. Together they form a unique fingerprint.

Cite this